Marta a. Miyares

发表

A multidisciplinary team-based process improves outpatient anticoagulation quality with continuous-flow left-ventricular assist devices.

W. Baker, S. Chaparro, Yara M Kuyumjian, 2016, International journal of cardiology.

Reversing the action of newer oral anticoagulants--author's reply.

Marta a. Miyares, Kyle A. Davis, 2013, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Engaging in Collaborative Research: Focus on the Pharmacy Practitioner

L. Schulz, J. Mazur, M. Badowski, 2017, Hospital pharmacy.

Community-Based Interventions to Improve Outcomes for Cardiovascular Disease [Letter]

Marta a. Miyares, Kyle A. Davis, 2014, Preventing chronic disease.

Newer oral anticoagulants: a review of laboratory monitoring options and reversal agents in the hemorrhagic patient.

Marta a. Miyares, Kyle A. Davis, Marta A. Miyares, 2012, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Idarucizumab, a Humanized, Monoclonal Antibody Fragment for Immediate Reversal of Dabigatran

Yara M Kuyumjian, Marta a. Miyares, S. Eaves, 2015, Journal of pharmacy practice.

Caution warranted when defining contraindications in initiating β-blocker therapy.

Marta a. Miyares, 2014, JAMA internal medicine.

Comment: clinical experience with prophylactic fondaparinux in critically ill patients with moderate to severe renal impairment or renal failure requiring renal replacement therapy.

Marta a. Miyares, 2015, The Annals of pharmacotherapy.

Development of an Anticoagulation Stewardship Program at a Large Tertiary Care Academic Institution

Marta a. Miyares, Mariann Padron, 2015, Journal of pharmacy practice.

Additional considerations to precede selection of enoxaparin therapy.

Marta a. Miyares, 2013, JAMA internal medicine.

Clinical challenges in a patient with dabigatran-induced fatal hemorrhage.

Marta a. Miyares, E. Cano, Marta A. Miyares, 2012, The American journal of geriatric pharmacotherapy.

Direct-Acting Oral Anticoagulants as Emerging Treatment Options for Heparin-Induced Thrombocytopenia

Marta a. Miyares, Kyle A. Davis, Marta A. Miyares, 2015, The Annals of pharmacotherapy.

Optimizing Transition of Care Through the Facilitation of a Pharmacist-Managed Deep Vein Thrombosis Treatment Program

Marta a. Miyares, Kyle A. Davis, Venessa Price-Goodnow, 2013, Journal of pharmacy practice.

Progression to hepatitis and fibrosis secondary to lomitapide use: selecting the next course of action.

Marta a. Miyares, 2014, JAMA internal medicine.

Lomitapide: A novel agent for the treatment of homozygous familial hypercholesterolemia.

Marta a. Miyares, Kyle A. Davis, Marta A. Miyares, 2014, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

One-Year Risk of Bleeding With Dabigatran in Patients With Atrial Fibrillation: Placing Real-World Results Into Perspective.

Marta a. Miyares, 2015, JAMA internal medicine.

Antithrombin III Utilization in a Large Teaching Hospital.

Cristina M Salas, Marta a. Miyares, Marta A. Miyares, 2013, P & T : a peer-reviewed journal for formulary management.

Comment: efficacy and safety of argatroban and bivalirudin in patients with suspected heparin-induced thrombocytopenia.

Marta a. Miyares, 2015, The Annals of pharmacotherapy.

Development and implementation of a hyperglycemic emergency protocol.

Marta a. Miyares, Ariel Zlicha, Jeanette N Rodriguez, 2013, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Anacetrapib and Dalcetrapib: Two Novel Cholesteryl Ester Transfer Protein Inhibitors

Marta a. Miyares, Marta A. Miyares, 2011, The Annals of pharmacotherapy.

Serelaxin, a 'breakthrough' investigational intravenous agent for acute heart failure.

Marta a. Miyares, Kyle A. Davis, Marta A. Miyares, 2013, P & T : a peer-reviewed journal for formulary management.

Dual antiplatelet therapy with clopidogrel and aspirin after ischemic stroke: A review of the evidence.

Marta a. Miyares, E. Dietrich, Kyle A. Davis, 2015, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Potential cost savings associated with dose rounding antineoplastic monoclonal agents

Marta a. Miyares, Marcos Viera, Alexander Heyliger, 2015, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Patient considerations and clinical impact of cholesteryl ester transfer protein inhibitors in the management of dyslipidemia: focus on anacetrapib

Marta a. Miyares, Kyle A. Davis, Marta A. Miyares, 2012, Vascular health and risk management.

Comment

Marta a. Miyares, 2015 .

Comment: Pulmonary Embolism After Early Change From Rivaroxaban to Aspirin Following Total Knee Replacement in an Obese Patient.

Marta a. Miyares, 2015, The Annals of pharmacotherapy.

Community-Based Interventions to Improve Outcomes for Cardiovascular Disease [Letter]

Marta a. Miyares, Kyle A. Davis, 2014, Preventing Chronic Disease.